The link between overuse and burnout
Doctors' experiences show how the systemic factors that lead to overuse and waste are also causing widespread burnout. More
What do the Shkreli Award winners have in common?
On the Relentless Health Value podcast, Shannon Brownlee and Vikas Saini discuss this year's Shkreli Award winners. More
How retail pharmacy policies drive overprescribing
A recent New York Times investigation revealed that retail pharmacies are pressuring pharmacists to fill prescriptions at an unsafe pace, leading to overprescribing and medication errors. More
More coverage but more cost: Are we better off now than 20 years ago?
Uninsurance rates have fallen over the past 20 years, but has health care become more affordable? More
Should hospitals be judged by their billing practices?
Affordability is one of the most important considerations for hospital patients. So why isn't billing taken into account in hospital evaluations? More
The secret harms of cancer screening
"Screening saves lives" is a popular sentiment. But what about the potential downsides of cancer screening? More
The true cost of “free” samples
Many physicians see drug samples as a benefit, because they can give pills to patients who may not be able to afford the medication otherwise. But are these "free" samples really free? More
Ashley’s Sample Post
An example of an abstract. Enter an abstract here. More
PRESS RELEASE: Report shows California trades spending on vital community conditions that keep people healthy for propping up a sick-care system
Report finds health care spending grew 146 percent in the past decade—wasting billions in the process on overpriced services and unnecessary care—while spending on community conditions grew by just 39 percent. More
Custom Block Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent varius odio orci, ac faucibus elit varius eu. Aliquam consectetur pulvinar justo posuere laoreet. Aenean mi dui, dapibus et imperdiet eget, feugiat at arcu. Sed et ex in tellus molestie sodales tincidunt id massa. Donec rutrum consectetur dapibus. Curabitur fringilla, magna eu tristique pellentesque, metus turpis […] More
PRESS RELEASE: Growing epidemic of medication overload impacting millions of older Americans
In a new report, the Lown Institute calls for a national action plan to address overprescribing. More
The most influential articles on overuse from 2017
Each year, JAMA Internal Medicine publishes an update on overuse, featuring the top ten most influential articles on overuse from the previous year. Here are some highlights from this year's update! More
The real reason why ORBITA is groundbreaking
If you thought the only takeaway from ORBITA was "stents don't work," you're missing the point, says Dr. Vikas Saini in Health Affairs. More
Arthroscopic decompression no better than “sham” for shoulder pain, study finds
If stents for stable angina don't work, what else doesn't work? As it turns out, arthroscopic surgery for shoulder pain... More
The ORBITA debate continues: Authors refute letters in The Lancet
The ORBITA debate continues as the study authors respond to critical letters in The Lancet. More
What’s the harm in earlier screening for colorectal cancer?
Cancer advocacy groups are cheering the new screening guidelines for colorectal cancer, but few reports have examined both the costs and benefits of lowering the age of screening. More
The CABANA trial: Another cardiac procedure bites the dust?
Catheter ablation for atrial fibrillation has been used for 20 years, and grown into a $4.5 billion industry. But is the procedure actually effective? More
Has “Less is More” gone too far? The New England Journal says it has.
Are we oversimplifying the discussion when it comes to overuse? In a NEJM editorial, Lisa Rosenbaum argues that "less is more" can be a slippery slope. Here's what we thought about her controversial piece. More
Can one study change clinical practice?
Professor Doug McKell explains why ORBITA might not be enough to reduce unnecessary stents. More
HPV protection or cancer vaccine? Putting Gardasil in context
Why was Gardasil originally marketed as a cervical cancer vaccine? Professor Samantha Gottlieb explains. More